CRTHF (CARsgen Therapeutics Holdings) Dividend Yield %: 0.00% (As of Jul. 08, 2026)


CRTHF CARsgen Therapeutics Holdings Ltd CRTHF
24 GF Score
Price $2.08
! 3 Warning Signs
View Full Analysis

What is CARsgen Therapeutics Holdings Dividend Yield %?

CARsgen Therapeutics Holdings CRTHF 24 Dividend Yield % is 0.00% as of Jul. 08, 2026. GuruFocus rates CRTHF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 153 Biotechnology companies, CARsgen Therapeutics Holdings ranks worse than 653594.12% on this metric.

As of today (2026-07-08), the Trailing Annual Dividend Yield of CARsgen Therapeutics Holdings is 0.00%.

The historical rank and industry rank for CARsgen Therapeutics Holdings's Dividend Yield % or its related term are showing as below:

CRTHF's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.31
* Ranked among companies with meaningful Dividend Yield % only.

CARsgen Therapeutics Holdings's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

As of today (2026-07-08), the Forward Dividend Yield % of CARsgen Therapeutics Holdings is 0.00%.

CARsgen Therapeutics Holdings's Dividends per Share for the six months ended in Dec. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


CARsgen Therapeutics Holdings  (OTCPK:CRTHF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


CARsgen Therapeutics Holdings Dividend Yield % Related Terms


CARsgen Therapeutics Holdings Dividend Yield % Historical Data

* Premium members only.

The historical data trend for CARsgen Therapeutics Holdings's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARsgen Therapeutics Holdings Dividend Yield % Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CRTHF vs VRTX, REGN, ALNY: Dividend Yield % Comparison

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CARsgen Therapeutics Holdings Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's Dividend Yield % falls into.


CRTHF
24GF Score
CARsgen Therapeutics Holdings Ltd CRTHF
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARsgen Therapeutics Holdings Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
CARsgen Therapeutics Holdings (CRTHF) has a Dividend Yield % of 0.00% as of Jul. 08, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on CARsgen Therapeutics Holdings and its competitors. According to the industry distribution chart, CARsgen Therapeutics Holdings ranks #999999 out of 153 companies in the Biotechnology industry.
Is CARsgen Therapeutics Holdings' Dividend Yield % too high?
CARsgen Therapeutics Holdings' current Dividend Yield % is 0.00%. Based on the distribution chart, CARsgen Therapeutics Holdings ranks #999999 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CARsgen Therapeutics Holdings has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does CARsgen Therapeutics Holdings' Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CARsgen Therapeutics Holdings ranks #999999 out of 153 companies for Dividend Yield %. This places CARsgen Therapeutics Holdings in the lower half of its industry. The industry median Dividend Yield % is 1.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.31, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on CARsgen Therapeutics Holdings and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CARsgen Therapeutics Holdings's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARsgen Therapeutics Holdings stock overvalued right now?
CARsgen Therapeutics Holdings (CRTHF) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. CARsgen Therapeutics Holdings' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For CARsgen Therapeutics Holdings (CRTHF), the current Dividend Yield % is 0.00% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CARsgen Therapeutics Holdings Business Description

Other Exchanges 02171:Hong Kong
Address No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America. During the year, a majority of the Group's revenue was derived from one customer located in the Chinese mainland.
24GF Score

Get the complete analysis for CRTHF

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.08
Price